vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $93.5M, roughly 1.6× COMSCORE, INC.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 3.2%, a 4.6% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $2.9M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 3.8%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
NUTX vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $93.5M |
| Net Profit | $11.8M | $3.0M |
| Gross Margin | 30.4% | 41.0% |
| Operating Margin | 20.4% | 7.0% |
| Net Margin | 7.8% | 3.2% |
| Revenue YoY | -41.1% | -1.5% |
| Net Profit YoY | -80.8% | -3.7% |
| EPS (diluted) | $2.34 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $93.5M | ||
| Q3 25 | $267.8M | $88.9M | ||
| Q2 25 | $244.0M | $89.4M | ||
| Q1 25 | $211.8M | $85.7M | ||
| Q4 24 | $257.6M | $94.9M | ||
| Q3 24 | $78.8M | $88.5M | ||
| Q2 24 | $76.1M | $85.8M | ||
| Q1 24 | $67.5M | $86.8M |
| Q4 25 | $11.8M | $3.0M | ||
| Q3 25 | $55.4M | $453.0K | ||
| Q2 25 | $-17.7M | $-9.5M | ||
| Q1 25 | $21.2M | $-4.0M | ||
| Q4 24 | $61.6M | $3.1M | ||
| Q3 24 | $-8.8M | $-60.6M | ||
| Q2 24 | $-364.0K | $-1.7M | ||
| Q1 24 | $-364.0K | $-1.1M |
| Q4 25 | 30.4% | 41.0% | ||
| Q3 25 | 57.8% | 40.6% | ||
| Q2 25 | 51.2% | 40.6% | ||
| Q1 25 | 55.9% | 39.6% | ||
| Q4 24 | 55.0% | 42.4% | ||
| Q3 24 | 27.8% | 41.2% | ||
| Q2 24 | 29.7% | 39.5% | ||
| Q1 24 | 15.1% | 42.3% |
| Q4 25 | 20.4% | 7.0% | ||
| Q3 25 | 48.7% | 1.9% | ||
| Q2 25 | 13.8% | -1.9% | ||
| Q1 25 | 38.1% | -2.4% | ||
| Q4 24 | 44.4% | 4.1% | ||
| Q3 24 | 12.3% | -67.4% | ||
| Q2 24 | 7.0% | -2.2% | ||
| Q1 24 | 2.1% | -2.2% |
| Q4 25 | 7.8% | 3.2% | ||
| Q3 25 | 20.7% | 0.5% | ||
| Q2 25 | -7.3% | -10.6% | ||
| Q1 25 | 10.0% | -4.7% | ||
| Q4 24 | 23.9% | 3.3% | ||
| Q3 24 | -11.2% | -68.5% | ||
| Q2 24 | -0.5% | -2.0% | ||
| Q1 24 | -0.5% | -1.2% |
| Q4 25 | $2.34 | $9.50 | ||
| Q3 25 | $7.76 | $-0.86 | ||
| Q2 25 | $-2.95 | $-2.73 | ||
| Q1 25 | $3.33 | $-1.66 | ||
| Q4 24 | $11.56 | $-0.47 | ||
| Q3 24 | $-1.72 | $-12.79 | ||
| Q2 24 | $-0.07 | $-1.19 | ||
| Q1 24 | $-0.08 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $329.4M | $111.4M |
| Total Assets | $918.5M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $23.6M | ||
| Q3 25 | $166.0M | $26.7M | ||
| Q2 25 | $96.7M | $26.0M | ||
| Q1 25 | $84.7M | $31.0M | ||
| Q4 24 | $40.6M | $29.9M | ||
| Q3 24 | $46.9M | $20.0M | ||
| Q2 24 | $40.8M | $14.7M | ||
| Q1 24 | $30.0M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $329.4M | $111.4M | ||
| Q3 25 | $317.2M | $-26.3M | ||
| Q2 25 | $235.3M | $-21.7M | ||
| Q1 25 | $176.9M | $-13.5M | ||
| Q4 24 | $132.4M | $-8.3M | ||
| Q3 24 | $60.4M | $-2.7M | ||
| Q2 24 | $62.7M | $45.8M | ||
| Q1 24 | $63.0M | $51.4M |
| Q4 25 | $918.5M | $407.7M | ||
| Q3 25 | $964.5M | $406.9M | ||
| Q2 25 | $841.0M | $415.9M | ||
| Q1 25 | $761.9M | $421.5M | ||
| Q4 24 | $655.3M | $430.2M | ||
| Q3 24 | $438.5M | $412.5M | ||
| Q2 24 | $422.4M | $474.1M | ||
| Q1 24 | $404.3M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $3.2M |
| Free Cash FlowOCF − Capex | $69.0M | $2.9M |
| FCF MarginFCF / Revenue | 45.5% | 3.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 5.95× | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $3.2M | ||
| Q3 25 | $99.5M | $9.5M | ||
| Q2 25 | $27.3M | $932.0K | ||
| Q1 25 | $51.0M | $9.1M | ||
| Q4 24 | $54.0K | $-10.0M | ||
| Q3 24 | $6.8M | $12.5M | ||
| Q2 24 | $13.3M | $8.7M | ||
| Q1 24 | $3.1M | $6.9M |
| Q4 25 | $69.0M | $2.9M | ||
| Q3 25 | $99.2M | $9.4M | ||
| Q2 25 | $26.5M | $787.0K | ||
| Q1 25 | $50.9M | $8.7M | ||
| Q4 24 | $-341.0K | $-10.3M | ||
| Q3 24 | $6.2M | $12.4M | ||
| Q2 24 | $12.7M | $8.5M | ||
| Q1 24 | $2.3M | $6.6M |
| Q4 25 | 45.5% | 3.1% | ||
| Q3 25 | 37.0% | 10.5% | ||
| Q2 25 | 10.9% | 0.9% | ||
| Q1 25 | 24.0% | 10.1% | ||
| Q4 24 | -0.1% | -10.8% | ||
| Q3 24 | 7.8% | 14.0% | ||
| Q2 24 | 16.7% | 10.0% | ||
| Q1 24 | 3.4% | 7.6% |
| Q4 25 | 0.9% | 0.3% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 0.2% | 0.2% | ||
| Q3 24 | 0.8% | 0.1% | ||
| Q2 24 | 0.7% | 0.2% | ||
| Q1 24 | 1.1% | 0.3% |
| Q4 25 | 5.95× | 1.07× | ||
| Q3 25 | 1.80× | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
